AGP Executive Report
Last update: 11 hours agoHemp Compliance Crackdown: Hawaiʻi starts statewide enforcement July 1 for hemp retailer/distributor registration and product compliance, ending a grace period and warning online/out-of-state sellers to register and meet THC limits. Rescheduling Hearing Setup: A DEA judge set the schedule for next week’s marijuana rescheduling hearing, with presentations from government and multiple stakeholder groups. Medicinal Cannabis Driving Rules: NSW’s Road Transport Amendment would stop automatic penalties for eligible medicinal cannabis patients when THC is detected—if they’re registered, prescribed, and not impaired—while roadside testing and 24-hour bans still apply pending lab results. Policy Shift in Ireland: An Oireachtas committee recommends fully decriminalising possession of drugs for personal use by repealing Misuse of Drugs Act Section 3, pushing a health-led approach. Research & Product Development: eXoZymes won a $2.03M NIH SBIR grant to engineer rare cannabinoids and cannabinoid analogs for pharmaceutical evaluation. Industry Trust Theme: A CBD sector commentary argues the next phase depends on validation—quality standards and clinical proof—not just awareness.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
